Date: 2019-09-27Category: Not ApplicableState: Union GovernmentCountry: Europe
Decision (EU) 2019/1485 of the European Parliament of 26 March 2019 on discharge in respect of the implementation of the budget of the European Medicines Agency (EMA) for the financial year 2017
Executive Summary:
This document is a decision by the European Parliament concerning the discharge of the Executive Director of the European Medicines Agency (EMA) in respect of the implementation of the Agency's budget for the financial year 2017. It grants discharge, sets out observations in a resolution, and instructs the President to forward the decision and resolution to relevant parties for publication in the Official Journal of the European Union. The decision was made on March 26, 2019.
Key Points / Main Content:
* **Discharge:**
* The Executive Director of the EMA is granted discharge in respect of the implementation of the Agency's budget for the financial year 2017.
* Observations related to the discharge are detailed in a separate resolution.
* **Instructions:**
* The President of the European Parliament is instructed to forward the decision and the integral resolution to:
* The Executive Director of the EMA
* The Council
* The Commission
* The Court of Auditors
* The President is also instructed to arrange for the publication of the decision and resolution in the Official Journal of the European Union L series.
Impact Analysis:
* **Executive Director of the European Medicines Agency:**
* Impact: Granted discharge for the implementation of the Agency's 2017 budget.
* Action Required: Receive the decision and resolution.
* **Council, Commission, and Court of Auditors:**
* Impact: Informed of the discharge decision and related resolution.
* Action Required: Receive the decision and resolution.
* **President of the European Parliament:**
* Impact: Responsible for ensuring the decision is properly communicated and published.
* Action Required: Forward the decision and resolution to the specified parties and arrange for publication in the Official Journal.
Key Entities Referenced
European Parliament: A legislative body of the European Union.
European Medicines Agency: A European Union agency responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU.
Court of Auditors: The European Court of Auditors is the institution of the European Union (EU) established to audit EU finances.
Treaty on the Functioning of the European Union: One of the primary treaties of the European Union.
Council of the European Union: A component of the EU legislative branch in which ministers from each national government meet to adopt laws and coordinate policies.
Commission: Refers to the European Commission, an executive branch of the European Union responsible for proposing legislation, implementing decisions, and managing the EU budget.
Regulation EU, Euratom No 966/2012: A regulation of the European Parliament and of the Council on the financial rules applicable to the general budget of the Union.
Regulation EC No 726/2004: A regulation of the European Parliament and of the Council laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency.
27.9.2019 EN Official Journal of the European Union L 249/233
DECISION (EU) 2019/1485 OF THE EUROPEAN PARLIAMENT
of 26 March 2019
on discharge in respect of the implementation of the budget of the European Medicines Agency
(EMA) for the financial year 2017
THE EUROPEAN PARLIAMENT,
— having regard to the final annual accounts of the European Medicines Agency for the financial year 2017,
— having regard to the Court of Auditors' report on the annual accounts of the European Medicines Agency for the
financial year 2017, together with the Agency's reply (1),
— having regard to the statement of assurance (2) as to the reliability of the accounts and the legality and regularity of
the underlying transactions provided by the Court of Auditors for the financial year 2017, pursuant to Article 287
of the Treaty on the Functioning of the European Union,
— having regard to the Council's recommendation of 12 February 2019 on discharge to be given to the Agency in
respect of the implementation of the budget for the financial year 2017 (05825/2019 – C8-0075/2019),
— having regard to Article 319 of the Treaty on the Functioning of the European Union,
— having regard to Regulation (EU, Euratom) No 966/2012 of the European Parliament and of the Council of
25 October 2012 on the financial rules applicable to the general budget of the Union and repealing Council
Regulation (EC, Euratom) No 1605/2002 (3), and in particular Article 208 thereof,
— having regard to Regulation (EU, Euratom) 2018/1046 of the European Parliament and of the Council of 18 July
2018 on the financial rules applicable to the general budget of the Union, amending Regulations (EU)
No 1296/2013, (EU) No 1301/2013, (EU) No 1303/2013, (EU) No 1304/2013, (EU) No 1309/2013, (EU)
No 1316/2013, (EU) No 223/2014, (EU) No 283/2014, and Decision No 541/2014/EU and repealing Regulation
(EU, Euratom) No 966/2012 (4), and in particular Article 70 thereof,
— having regard to Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004
laying down Community procedures for the authorisation and supervision of medicinal products for human and
veterinary use and establishing a European Medicines Agency (5), and in particular Article 68 thereof,
— having regard to Commission Delegated Regulation (EU) No 1271/2013 of 30 September 2013 on the framework
financial regulation for the bodies referred to in Article 208 of Regulation (EU, Euratom) No 966/2012 of the
European Parliament and of the Council (6), and in particular Article 108 thereof,
— having regard to Rule 94 of and Annex IV to its Rules of Procedure,
— having regard to the report of the Committee on Budgetary Control and the opinion of the Committee on the
Environment, Public Health and Food Safety (A8-0135/2019),
1. Grants the Executive Director of the European Medicines Agency discharge in respect of the implementation of the
Agency's budget for the financial year 2017;
2. Sets out its observations in the resolution below;
3. Instructs its President to forward this decision, and the resolution forming an integral part of it, to the Executive
Director of the European Medicines Agency, the Council, the Commission and the Court of Auditors, and to arrange
for their publication in the Official Journal of the European Union (L series).
The President The Secretary-General
Antonio TAJANI Klaus WELLE
(1) OJ C 434, 30.11.2018, p. 141.
(2) OJ C 434, 30.11.2018, p. 141
(3) OJ L 298, 26.10.2012, p. 1.
(4) OJ L 193, 30.7.2018, p. 1.
(5) OJ L 136, 30.4.2004, p. 1.
(6) OJ L 328, 7.12.2013, p. 42.